MOTT, N.D. (KFYR) - The skies of Mott will shine bright on New Year’s Eve. Pyrotechnics professional Garrison Risner will ...
KT-333 is under clinical development by Kymera Therapeutics and currently in Phase I for Unspecified B-Cell Lymphomas.